Interleukin-33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species-mediated inhibition of nuclear factor kappa-B signal and stemness properties.
MedComm (2020)
; 5(5): e562, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38737470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
MedComm (2020)
Year:
2024
Document type:
Article
Country of publication:
China